We are live on
!
Find out more
CRB
Chad R. Baker Portfolio holdings
AUM
$620M
1-Year Est. Return
42.67%
This Fund
S&P 500
This Quarter
Est. Return
-1.15%
1 Year Est. Return
+42.67%
3 Year Est. Return
+108.31%
5 Year Est. Return
+132.07%
10 Year Est. Return
+563.15%
AUM
$253M
AUM Growth
+$222K
(+0.09%)
Cap. Flow
+$5.53M
Cap. Flow
% of AUM
2.18%
Top 10 Holdings %
Top 10 Hldgs %
38.67%
Holding
59
New
2
Increased
15
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Analog Devices
ADI
|
+$1.34M |
| 2 |
Gilead Sciences
GILD
|
+$1.23M |
| 3 |
Biogen
BIIB
|
+$1.1M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$198K |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$166K |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.2% |
| 2 | Industrials | 20.01% |
| 3 | Technology | 17.15% |
| 4 | Communication Services | 9% |
| 5 | Consumer Staples | 8.68% |
Similar funds
RC
TTSTC
KFAS
KGAMU
RIS
AMG
BWP
MC
Chad R. Baker's Q1 2018 Portfolio in Review
As of Q1 2018, Chad R. Baker held 59 positions worth $253M, up 0.09% from $253M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Trading was light in Q1 2018: portfolio turnover was 3.4%. Chad R. Baker opened 2 new positions and made no exits, leaving the 59-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 26% a quarter earlier, followed by Industrials and Technology.
- Chad R. Baker's largest Q1 2018 buy was Gilead Sciences: 15,500 shares worth $1.17M.
- Chad R. Baker added most to Analog Devices in Q1 2018, an estimated $1.34M increase.
- Chad R. Baker's ten largest holdings make up 39% of its $253M portfolio in Q1 2018.
- Chad R. Baker opened 2 new positions and closed 0 in Q1 2018.
- Chad R. Baker's portfolio value rose 0.09% quarter-over-quarter to $253M.
Based on Chad R. Baker's 13F filing for Q1 2018, filed 14 May 2018.